No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Morgan Stanley Maintains Third Harmonic Bio(THRD.US) With Hold Rating, Raises Target Price to $5.23
Raymond James Maintains Third Harmonic Bio(THRD.US) With Hold Rating
Top 3 Health Care Stocks You May Want To Dump This Quarter
Here's Why We're Not Too Worried About Third Harmonic Bio's (NASDAQ:THRD) Cash Burn Situation
Express News | Third Harmonic Bio Inc : Morgan Stanley Raises Target Price to $5.23 From $5.00
Third Harmonic Bio, Inc. Liquidation and Shareholder Distribution: Analyst Maintains Hold Rating Amid Strategic Uncertainties